NATALIE EMMERT: Open Payments
NPI 1285058081 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 87 payments from 15 companies in 2025. Trend: 2023 $1,106 · 2024 $1,731 · 2025 $1,704
Food & beverage: $1,604Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $381 |
| Galderma Laboratories, L.P. | 13 | $285 |
| Amgen Inc. | 9 | $274 |
| Janssen Biotech, Inc. | 23 | $243 |
| Novartis Pharmaceuticals Corporation | 8 | $144 |
| GENZYME CORPORATION | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Incyte Corporation | 2 | $55 |
| Lilly USA, LLC | 3 | $53 |
| Organogenesis Inc. | 1 | $31 |
Products named: NEMLUVIO, RINVOQ, TREMFYA, UPLIZNA, DUPIXENT, SKYRIZI, OTEZLA, COSENTYX.
Industry payments across IN — which companies pay providers there.
